Login to Your Account

FDA on Hot Seat as Congress Probes Compounding Imbroglio

By Marie Powers
Staff Writer

Thursday, November 15, 2012

In questioning by members of the House Energy and Commerce Committee, FDA Commissioner Margaret A. Hamburg was hammered for more than four hours Wednesday about the agency's failure to communicate proactively with the Massachusetts Department of Public Health or to provide adequate oversight of the New England Compounding Center, which has been implicated in 32 deaths and more than 400 additional illnesses from a fungal meningitis outbreak across 19 states.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription